Semaglutide for osteoarthritis

Areas affected by osteoarthritis

A recent study published in the New England Journal of Medicine on October 31, 2024, highlights that once-weekly semaglutide significantly reduces body weight and alleviates pain related to knee osteoarthritis in individuals with obesity, compared to a placebo.

Study Overview

Ozempic, a form of semaglutide

The study, led by Henning Bliddal, M.D., from Copenhagen University Hospital at Bispebjerg and Frederiksberg in Denmark, was conducted over 68 weeks at 61 sites across 11 countries. A total of 407 participants with obesity and clinically confirmed moderate knee osteoarthritis characterized by moderate to severe pain were enrolled. Participants were randomly assigned in a 2:1 ratio to receive either once-weekly subcutaneous semaglutide or a placebo, in addition to counseling on physical activity and a reduced-calorie diet.

Key Findings

The study results demonstrated the following:

• Body Weight Reduction: By week 68, participants receiving semaglutide experienced a mean body weight reduction of −13.7%, compared to −3.2% in the placebo group.
• Pain Reduction: The mean change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score was −41.7 points for the semaglutide group, compared to −27.5 points for the placebo group.
• Improvement in Physical Function: The 36-Item Short Form Health Survey (SF-36) indicated greater improvement in physical function among the semaglutide group, with a mean increase of 12.0 points compared to 6.5 points in the placebo group.

The incidence of serious adverse events was similar between the two groups, indicating that semaglutide was well-tolerated.

References

• NEJM study - Semaglutide for Osteoarthritis

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

Tired of Being Overweight?

Achieve lasting results with W8MD's proven weight loss program, trusted by thousands since 2011. Our comprehensive approach tackles weight gain factors like insulin resistance to help you lose weight and keep it off.

Tailored Weight Loss Solutions

W8MD offers personalized weight loss plans, including FDA-approved medications and GLP-1 injections, such as:

• Wegovy
• Zepbound
• Zepbound/Mounjaro
• Liraglutide (brand names: Saxenda/Victoza)

Other options include:

• Phentermine
• Contrave
• Phentermine/topiramate
• Semaglutide
• Tirzepatide

We also offer nutritious, low-glycemic foods and meal replacements to keep you on track.

Convenient Locations

W8MD provides weight loss services in Brooklyn, New York and Greater Philadelphia, with tailored plans and GLP-1 weight loss injections.

Looking for a weight loss clinic in Brooklyn or weight loss doctors in NYC? W8MD's expert team is here to help.

W8MD weight loss doctors

Weight Loss Doctor in NYC

Trust W8MD's best weight loss doctors in NYC for personalized solutions, including wiki Physician Weight Loss Program and GLP-1 injections.

W8MD Weight Loss Clinic in Philadelphia

W8MD in Philadelphia offers FDA-approved medications and weight loss injections. Visit our medical weight loss clinic for expert care.

Find the best weight loss tips in Philadelphia with W8MD.

Take the First Step

Book your consultation today and start your journey:

• Visit W8MD Official Site
• Check out Yelp reviews
• Schedule via Patient Fusion

Call now for medical weight loss:

• NYC: 718-946-5500
• Philadelphia: 215-676-2334

Explore W8MD's NYC Physician Weight Loss Program now!

• Individual results may vary!